Company Announcements

NEWS RELEASE | 10 February 2026

ISSUE OF SHARES

GreenX Metals Limited (GreenX or Company) advises that further to its announcements made on 24 November 2025, 2 December 2025, 12 December 2025 and 28 January 2026 the Company has issued the following ordinary fully paid shares (Shares):

·      2,799,099 Shares on the exercise of 4,775,000 unlisted options pursuant to cash and cashless exercise facilities;

·      3,487,147 Shares as deferred consideration for the acquisition of 90% of the Tannenberg Copper Project;

·      1,141,409 and 220,000 Shares as deferred consideration for the acquisition of the Eleonore North Project and to a consultant in lieu of cash, respectfully; and

·      16,000,000 Shares on completion of the Placement to raise gross proceeds of A$13.6 million.

An application has been made for the admission of 23,647,655 Shares to the Equity shares (international commercial companies secondary listing) listing segment of the Official List of the FCA (Official List) and to trading on the main market of the London Stock Exchange for listed securities (LSE Admission). LSE Admission is expected to take place on or about 20 February 2026.  

For the purposes of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules (DTRs), following LSE Admission, the Company's issued ordinary share capital will be 310,730,744 ordinary shares. The above figure of 310,730,744 may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company following LSE Admission.

GreenX has the following securities on issue:

·      310,730,744 ordinary fully paid shares;

·      11,000,000 performance rights that have an expiry date 8 October 2026;

·      5,525,000 unlisted options exercisable at A$0.55 each on or before 30 November 2026;

·      7,100,000 unlisted options exercisable at A$1.05 each on or before 31 May 2029; and

·      7,100,000 unlisted options exercisable at A$1.20 each on or before 31 May 2030.

As disclosed and predicted in the Company's announcement on 30 January 2026, the Company confirms that Poland has now applied to the Court of Appeal of the Republic of Singapore to appeal the dismissal of the ECT set-aside motion (refer to announcement dated 9 January 2026).

The threshold to succeed on a set aside motion in the Singapore courts is very high, with the courts rejecting set-aside applications in the vast majority of cases.

Please refer to the Company's announcements on 9 January 2026 and 30 January 2026 for further details.

Enquiries: